ScholarLens Back to search
1968•British Journal of RadiologyRequires access

A comparative study of a new low-viscous contrast agent SH 841 A Urovison and Urografin 76% in intravenous pyelography

J Praestholm, Jens Bojsen‐Møller, Else Frede Larsen

Open publisher page 1 citations

Abstract

A new low-viscous contrast agent SH 841 A Urovison has been used for intravenous pyelography in 148 patients. A control series of 116 patients have been examined with Urografin 76%. In spite of the fact that the patients in the Urovison group have received 12 per cent less iodine than the patients in the control group the pyelograms are of the same quality in the two groups. The frequency of minor side effects was practically identical in the two series and there were no serious side effects. The effect of Urovison's lower viscosity on injection rates is demonstrated experimentally.

About this research paper

What this paper is about

A new low-viscous contrast agent SH 841 A Urovison has been used for intravenous pyelography in 148 patients. A control series of 116 patients have been examined with Urografin 76%. In spite of the fact that the patients in the Urovison group have received 12 per cent less iodine than the patients in the control group the pyelograms are of the same quality in the two groups. The frequency of minor side effects was practically identical in the two series and there were no serious side effects. The effect of Urovison's lower viscosity on injection rates is demonstrated experimentally.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A new low-viscous contrast agent SH 841 A Urovison has been used for intravenous pyelography in 148 patients. A control series of 116 patients have been examined with Urografin 76%. In spite of the fact that the patients in the Urovison group have received 12 per cent less iodine than the patients in the control group the pyelograms are of the same quality in the two groups. The frequency of minor side effects was practically identical in the two series and there were no serious side effects. The effect of Urovison's lower viscosity on injection rates is demonstrated experimentally.

Key concepts: Intravenous pyelography, Medicine, Contrast (vision), Pyelogram, Iodine, Nuclear medicine, Anesthesia, Surgery

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A comparative study of a new low-viscous contrast agent SH 841 A Urovison and Urografin 76% in intravenous pyelography — Research Paper | ScholarLens